Search

Your search keyword '"Llaneras, Jordi"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Llaneras, Jordi" Remove constraint Author: "Llaneras, Jordi"
45 results on '"Llaneras, Jordi"'

Search Results

1. Emergency department contribution to HCV elimination in the Iberian Peninsula

2. Analysis of the reasons for requesting HIV serology in the emergency department other than those defined in the targeted screening strategy of the “Urgències VIHgila” program and its potential inclusion in a future consensus document

3. Análisis de los motivos de solicitud de serología del virus de la inmunodeficiencia humana (VIH) en urgencias diferentes a los definidos en la estrategia de detección dirigida del programa «Urgències VIHgila» y su potencial inclusión en un futuro documento de consenso

4. Outcomes of an extracorporeal cardiopulmonary resuscitation (ECPR) program for in- and out-of-hospital cardiac arrest in a tertiary hospital in Spain

6. Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination

7. mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels)

8. Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective‐prospective study.

10. Impact of specialized training for emergency department nurses screening or undetected HIV infection: the “Urgències VIHgila” project experience

12. Real‐life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.

13. Impacto de una formación específica y generalizada de los profesionales de enfermería en el despistaje en urgencias de infección oculta por VIH: experiencia del proyecto "Urgències VIHgila".

14. Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs

15. Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules

16. Real-life effectiveness of voxilaprevir/sofosbuvir/velpatasvir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

17. Impact of direct-acting antiviral therapy on survival in patients with liver cirrhosis and ascites. Data from the hepa-C registry

18. Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in hepatitis C patients with prior failure to DAA treatment

20. Patients with hepatitis B and D are more often linked to medical care than patients with hepatitis C

22. mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES Study (Chronic Hepatitis E Screening in patients with immune impairment and increased transaminases levels)

23. Emergency department contribution to HIV and HCV control in the Iberian Peninsula

24. Clinical impact and cost-effectiveness of hepatitis C testing in an emergency department in Barcelona, Spain

26. Efficacy and safety of daclatasvir‐based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study

29. THU-216 - Real-life effectiveness of voxilaprevir/sofosbuvir/velpatasvir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

30. THU-171 - Impact of direct-acting antiviral therapy on survival in patients with liver cirrhosis and ascites. Data from the hepa-C registry

34. Corrigendum to “Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules” [J Hepatol (2019) 874–884]

35. Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management

36. Screening and treatment difficulties of hepatitis C virus infected patients with substance use disorders or dual pathology, despite centralized management in an addiction and dual diagnosis center

38. Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

39. Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease

40. Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

42. Real-Life Effectiveness and Safety of Velpatasvir/Sofosbuvir/Voxilaprevir for Previously Daa Treated Patients with Chronic Hepatitis C

43. THU344 - Screening and treatment difficulties of hepatitis C virus infected patients with substance use disorders or dual pathology, despite centralized management in an addiction and dual diagnosis center.

44. Hepatitis C virus detection in hospital emergency departments.

45. Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination.

Catalog

Books, media, physical & digital resources